We report two pediatric patients who required blood priming for continuous
venovenous hemodiafiltration. Both of these patients developed a significan
t hypotensive episode with initiation of continuous venovenous hemodiafiltr
ation with immediate resolution on discontinuation. The most notable common
characteristics of these patients were the use of the Multi-flo 60 (AN-69)
dialyzer membrane and blood priming. No similar episodes were encountered
when patients were primed with saline or albumin. The AN-69 membrane is exq
uisitely pH sensitive, The lower the pH concentration of the blood passing
by the membrane, the greater the activation of bradykinin, a known hypotens
ive-inducing agent, by the dialyzer, On review of blood available from our
blood bank, the following parameters became apparent. The pH of standard bl
ood available from our blood bank ranged from 6.1 to 6,4, The blood obtaine
d from our blood bank had significant hyperkalemia, hyponatremia, and hypoc
alcemia. No reactions were noted when patients were primed with normal sali
ne, which has a pH of around 5,9, We speculate that the presence of endogen
ous blood substances, such as bradykinin, may have induced the hypotensive
episodes. We describe two techniques we developed that should allow for the
increased safe and effective use of the AN-69 membranes in continuous veno
venous hemodiafiltration circuits. These observations indicate the requirem
ent for careful and close attention to detail when delivering renal replace
ment therapy to anyone, but especially patients weighing less than 10 kg. (
C) 2001 by the National Kidney Foundation, Inc.